February 13, 2017
Ipsen acquires Sanofi’s five products for €83M
Ipsen has entered into a definitive agreement to acquire Sanofi’s five consumer healthcare products in certain European territories.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
February 13, 2017
Verona Pharma 10million newly consolidate ordinary shares
Verona Pharma said on Monday that, after the 50 for 1 share consolidation approved by shareholders on 8 February 2017, it now has 51,361,064 ordinary shares of £0.05 each in issue, each carrying one voting right.
February 13, 2017
Oxford BioDynamics welcomes Dr Claudio Carini to its Scientific Advisory Panel
Oxford BioDynamics, a biotechnology company focused on the discovery and development of novel epigenetic biomarkers for use within the pharmaceutical and biotechnology industry, has appointed Dr Claudio Carini as an Advisor, effective immediately.
February 13, 2017
STADA on target for two bidders, one being private equitiy firm Cinven
German drugmaker Stada has confirmed certain rumours about receiving takeover offers from a private equity firm, Cinven Partners and one other unnamed bidder.
February 13, 2017
Evgen Pharma inks services deal with APTrans
Evgen Pharma has signed a services agreement with APTrans for developing its anti-stress drug SFX-01, currently in phase II clinical testing. APTrans is a Cheshire-based consortium of drug development companies.
February 13, 2017
Premaitha signs four-year MPA with European diagnostics services group to install IONA test
Premaitha has signed four-year Master Procurement Agreement (the “MPA”) with a European diagnostics services group to install the IONA test in at least two of the Groups’s laboratories.
February 10, 2017
Redx positive about its prospects, raises £7million
“The new funds we are raising will support the ongoing progress of these important assets as well as the rest of our pipeline and we remain very positive about Redx’s prospects.”
February 10, 2017
Hybrigenics gives update on chronic myeloid leukemia study
Hybrigenics has given an update on the Phase II clinical study of inecalcitol in chronic myeloid leukemia (CML) administered in addition to imatinib, the reference inhibitor of BCR-ABL kinase used as standard of care for CML.
February 9, 2017
Pharmaceuticals Analytical Testing Outsourcing Market Worth $9.6 Billion By 2025
The consumption levels are anticipated to rise exponentially over the forecast period. The companies and government organizations are working collaboratively to bridge the gap between supply and demand.
February 9, 2017
Forward Pharma cashes in Biogen’s $1.25 billion
Forward Pharma has received $ 1.25 billion due to the settlement with Biogen’s subsidiaries, it made in January.